See the DrugPatentWatch profile for gadoterate
What is gadoterate meglumine, and what is it used for?
Gadoterate meglumine is a gadolinium-based contrast agent used in medical imaging, most commonly for MRI scans. It helps doctors see differences between tissues by improving the contrast of images. It is administered by injection into the bloodstream before the scan. [1]
How does it work in MRI?
Like other gadolinium contrast agents, gadoterate meglumine contains gadolinium, a metal that affects how nearby hydrogen atoms behave in a magnetic field. That effect changes the MRI signal, helping certain tissues and abnormalities appear more clearly on the scan. [2]
Is it considered a “gadolinium contrast,” and what are the key patient safety concerns?
Yes, it is a gadolinium-based contrast agent. A key safety issue with gadolinium agents is that, in some people—especially those with severe kidney problems—gadolinium can be linked to a rare condition called nephrogenic systemic fibrosis (NSF). Clinical use typically considers kidney function before giving gadolinium contrast. [1][3]
What do people usually search next: dosage, brand names, or side effects?
If you’re asking for dosing details, common brand names, or specific side effects, tell me the context (for example, MRI type and the patient’s kidney function status). Product labeling varies by country and indication, and those details depend on the prescribing information.
Sources
[1] https://dailymed.nlm.nih.gov/dailymed/drug-info.cfm?setid= (search: “gadoterate meglumine label”)
[2] https://radiopaedia.org/articles/gadolinium-contrast-agents
[3] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/gadolinium-based-contrast-agents#kidney